Guideline · Position statement or standards
Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand.
- Bronchopulmonary dysplasia
- Eyes and hearing
- Medical
- Neurodevelopmental follow-up
- Nursing
- Postnatal and transitional care
- Respiratory
- Retinopathy of prematurity
This guideline is from 2020, more than five years ago. Check whether a newer version exists and which version your unit follows.
Summary
This position statement guides the respiratory management of infants with chronic neonatal lung disease (CNLD) after discharge from the NICU, with particular focus on home supplemental oxygen therapy. It addresses target oxygen saturations during overnight oximetry, assessment of readiness for discharge on low-flow oxygen, and the monitoring and weaning of oxygen at home. It also considers comorbidities such as pulmonary hypertension, retinopathy of prematurity and growth, and the role of palivizumab in reducing RSV admissions. It is aimed at paediatricians, neonatologists, respiratory and sleep physicians and general practitioners.
Summary written for NICUlearn. Always read the original.
- Licence:
- Open (Creative Commons)
Guidelines are shown for education. Follow your unit's own guidance and senior advice.